Laval, QC – Servier Canada, the Canadian subsidiary of the Servier Research Group, the second largest French pharmaceutical company, has begun construction of a Centre of Excellence in Clinical Research at its Laval location.
This new 30,000 square-foot complex represents a $16.3 million investment and received the assistance of Investissement Québec and the strategic support of Montréal International. It will house activities for the Canadian International Centre for Therapeutic Research (ICTR) and the Servier Canada National Centre for Professional Training.
The centre’s mission is to help further the design and development of ICTR clinical research in major therapeutic areas including cardiovascular disease, cancer and neuropsychiatry. The company says the project will require it to hire additional staff, and a total of 38 new employees will join it in the coming months.
The company also says it expects to launch three innovative products over the next three years. “The Servier Research Group is increasing its research endeavours in Canada; the level of excellence and attractiveness of the research sector, particularly in Québec, make it an ideal location to advance therapeutic innovation,” said Emmanuel Canet, president of Servier R&D.